ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 837,40
0,86%
Dow Jones
44 156,73
0,30%
DAX
21 303,82
1,25%
Brent Oil
78,095
-0,31%
Bitcoin
102 114,25
-1,47%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. vTv Therapeutics Inc (VTVT) Cours

vTv Therapeutics Inc

vTv Therapeutics Inc (VTVT)

NASDAQ
13,48
-0,485
(-3,47%)
Fermé 23 Janvier 10:00PM
Retardé de 15 minutes
13,48
0,00
(0,00%)
Après les heures de négociation: 12:55AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
13,48
Prix Achat
11,31
Prix Vente
22,68
Volume échangé
13 068
13,48 Fourchette du Jour 14,2955
7,38 Plage de 52 semaines 30,99
Cap du marché
42,996M
Clôture Veille
13,965
Ouverture
13,86
Dernière Transaction
1
@
13.4
Dernière heure de transaction
Volume financier
US$ 182 987
VWAP
14,0027
Volume moyen (3 m)
28 083
Actions en circulation
3 189 606
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,12
Bénéfice par action (BPA)
-6,35
Chiffre d'affairess
-
Bénéfice net
-20,25M

À propos de vTv Therapeutics Inc

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (... vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
vtvtherapeutics.com
Siège social
Wilmington, Delaware, USA
Fondé
-
vTv Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker VTVT. Le dernier cours de clôture d'vTv Therapeutics était de US$13,97. Au cours de la dernière année, les actions de vTv Therapeutics ont été négociées dans une fourchette de prix de US$ 7,38 à US$ 30,99.

vTv Therapeutics compte actuellement 3 189 606 actions en circulation. La capitalisation boursière d'vTv Therapeutics est de US$44,54 million. vTv Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.12.

VTVT Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER PR Newswire WESTON, Fla., Dec. 9, 2024 WESTON, Fla., Dec. 9...

09 Décembre 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

06 Décembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

25 Octobre 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

23 Septembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

08 Août 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

08 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Juillet 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.51-3.645461043613.9914.3513.48454314.04053272CS
40.231.735849056613.2515.26213.2883613.93191028CS
12-0.27-1.9636363636413.7518.3712.622808315.13990321CS
26-7.68-36.294896030221.1624.8212.12012934615.74101607CS
525.3265.19607843148.1630.997.383573816.31533538CS
156-17.276-56.17115359630.756567.3816697128.72202088CS
260-89.72-86.9379844961103.2205.27.3888988499.73483173CS

VTVT - Frequently Asked Questions (FAQ)

What is the current vTv Therapeutics share price?
The current share price of vTv Therapeutics is US$ 13,48
How many vTv Therapeutics shares are in issue?
vTv Therapeutics has 3 189 606 shares in issue
What is the market cap of vTv Therapeutics?
The market capitalisation of vTv Therapeutics is USD 44,54M
What is the 1 year trading range for vTv Therapeutics share price?
vTv Therapeutics has traded in the range of US$ 7,38 to US$ 30,99 during the past year
What is the PE ratio of vTv Therapeutics?
The price to earnings ratio of vTv Therapeutics is -2,12
What is the reporting currency for vTv Therapeutics?
vTv Therapeutics reports financial results in USD
What is the latest annual profit for vTv Therapeutics?
The latest annual profit of vTv Therapeutics is USD -20,25M
What is the registered address of vTv Therapeutics?
The registered address for vTv Therapeutics is 251 LITTLE FALLS DRIVE, OAKS PKWY, WILMINGTON, DELAWARE, 19808
What is the vTv Therapeutics website address?
The website address for vTv Therapeutics is vtvtherapeutics.com
Which industry sector does vTv Therapeutics operate in?
vTv Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
ASSTAsset Entities Inc
US$ 1,36
(51,11%)
121,68M
STAIScanTech AI Systems Inc
US$ 2,12
(44,22%)
51,68M
JYDJayud Global Logistics Ltd
US$ 3,53
(42,91%)
1,27M
NTRBNutriband Inc
US$ 7,39
(41,84%)
3,88M
STFSStar Fashion Culture Holdings Ltd
US$ 2,62
(-80,61%)
30,25M
HEPAHepion Pharmaceuticals Inc
US$ 0,135
(-58,05%)
39,89M
STBXStarBox Group Holdings Ltd
US$ 0,6201
(-36,50%)
1,63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93,51
(-35,73%)
1
JUNSJupiter Neurosciences Inc
US$ 3,61
(-33,39%)
6,87M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6446
(30,75%)
296,43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3191
(33,57%)
229,11M
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
NVDANVIDIA Corporation
US$ 147,07
(4,43%)
216,62M
RGTIRigetti Computing Inc
US$ 13,89
(-0,64%)
154,54M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
VTVT
vTv Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés